Sacyourking

Time to buy CRSP

做多
NASDAQ:CRSP   CRISPR Therapeutics AG
Catalysts coming in 2022 and weekly trend changes based on heiken ashii candles, plus the bounce at 74+- which was prior resistance, plus analyst ratings make this an attractive buy for me at these levels.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。